Proposal for a Novel Methodology to Screen And Score Cost Versus Survival for Anticancer Drugs in Metastatic Disease: Could Cost Weigh in Evaluation?

Authors

Helmy M. Guirgis

University of California, Irvine, CA

Helmy M. Guirgis

Preview

Methodology with limits on cost per day of survival was proposed to evaluate anticancer drugs used in first-line therapy for metastatic disease. Cost versus survival varied with the number of cycles.